The difference between ALA and EPA/DHA — why it's not just chemistry

May 3, 2026

In this article

Why “omega-3” is a collective term, not a single substance
The distinction between short-chain (ALA) and long-chain (EPA, DHA) omega-3
Why ALA is a starting material that must be converted before the body can use it
What it means to provide EPA and DHA directly, and why that is different from providing ALA

Part of a series

Article 5 of 6 in a series on omega-3 in horses. The series is intended to be read oldest to newest — each article builds on the previous.

Previous: Why feeding linseed makes sense for coat — and what it doesn’t do

Next: The conversion step horses depend on — and why it often falls short

Omega-3 is not a single substance. It is a name given to a group of related fatty acids — and not all of them do the same job.

When people talk about omega-3, they tend to talk about it as though it were one thing. One nutrient, one effect, one question to answer: is my horse getting it or not?

In reality, omega-3 is a collective term — a name given to a group of related fatty acids that share a similar chemical structure. More specifically, omega-3 is a type of polyunsaturated fatty acid — one of several categories of fat found in food. What makes it distinct is its chemical structure, and what makes it useful is what the body can do with it.

But within the omega-3 group itself, the members are quite different molecules, and those differences determine what role each one plays in the body.

Understanding this is not a technical detail. It is the foundation for understanding whether any given approach to omega-3 supplementation is actually doing what you hope it is.

Short-chain and long-chain — what the difference means

Fatty acids — the building blocks of dietary fats — come in different lengths. That length is not just a structural detail. It determines what a fatty acid is capable of doing in the body, and how much work the body has to do before it can use it.

ALA — alpha-linolenic acid — is a short-chain omega-3. It is the form found in plant sources: fresh grass, linseed, chia, and other vegetable-based feeds. It is an essential nutrient, meaning the body cannot manufacture it and must obtain it through food. That makes it genuinely important.

But short-chain means it is a starting material. A building block. The body cannot use ALA directly in the tissues where omega-3 is expected to have an effect. It first has to convert ALA into longer, more complex forms — and those longer forms have their own names: EPA and DHA.

ALA is a short-chain omega-3 — a starting material. The body cannot use it directly in its tissues. It must first be converted into EPA and DHA: the long-chain forms that are the finished products the pathway is trying to produce.

EPA — eicosapentaenoic acid — and DHA — docosahexaenoic acid — are long-chain omega-3s. They are structurally more complex than ALA, and that complexity is what makes them functionally active. These are the forms the body actually uses in its tissues. They are not building blocks waiting to be converted. They are the finished product that the pathway is trying to produce.

The raw material and the finished product

A straightforward way to think about it: ALA is the raw ingredient. EPA and DHA are what gets made from it.

When a diet provides ALA, the body has to manufacture EPA and DHA itself before those molecules can be put to work. That manufacturing process happens inside the horse, through a series of chemical steps that progressively extend and modify the short-chain molecule into the longer-chain forms.

When EPA and DHA are provided directly — from algae, for example, which is the original source of all marine omega-3 — that manufacturing step is bypassed entirely. The body receives the finished product rather than the raw material.

When EPA and DHA are provided directly, the body receives the finished product rather than the raw material. The conversion step — with all its associated limits — is bypassed entirely.

This is the fundamental difference between plant-based omega-3 sources like linseed and direct sources of EPA and DHA. It is not that one is good and one is bad. It is that they enter the pathway at different points. One arrives as a raw material requiring further processing. The other arrives ready to use.

Why this matters for supplementation

Two horses can both be described as receiving omega-3 supplementation while sitting in quite different situations. One is receiving ALA — a building block that depends on conversion. The other is receiving EPA and DHA — the molecules the body would have produced from that conversion, supplied directly.

From a labelling perspective, both are being supplemented with omega-3. From a biological perspective, one horse's pathway is dependent on a manufacturing process that the body may or may not complete reliably. The other's is not.

Whether that manufacturing process is reliable — and what happens when it isn't.